🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

PRESS DIGEST- New York Times business news - Feb 29

Published 2016-02-29, 12:29 a/m
© Reuters.  PRESS DIGEST- New York Times business news - Feb 29
PSON
-
BHC
-

Feb 29 (Reuters) - The following are the top stories on the
New York Times business pages. Reuters has not verified these
stories and does not vouch for their accuracy.

- J. Michael Pearson (L:PSON) has returned as the chief executive of
Valeant Pharmaceuticals (N:VRX) VRX.TO after two months of medical
leave, setting him up for the challenge of restoring investor
confidence in the embattled company.

In a push for transparency since the 2008 financial
crisis, regulators asked banks to clearly disclose and explain
the terms of just about every financial product, including
credit cards and mortgages. But overdraft practices still come
with hidden costs and confusing terms, bank customers, lawyers
and consumer advocates say.

With a series of wins in key Republican primary states,
and with the billionaire's expected strong showing when 12
states hold primaries or caucuses on Tuesday, the European
media, like its American counterpart, is adjusting to the
prospect of a seemingly unstoppable Trump juggernaut.

The discovery of perfluorooctanoic acid, a toxic chemical
linked in some studies to an increased risk for cancer and
thyroid disease, in the Hoosick Falls, N.Y. has alarmed
residents, some of whom are critical of officials' response.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.